ARUN GUPTA: Open Payments
NPI 1841225166 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 20 payments from 11 companies in 2025. Trend: 2023 $552 · 2024 $358 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $236 |
| Alkermes, Inc. | 2 | $169 |
| E.R. Squibb & Sons, L.L.C. | 1 | $49 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Eisai Inc. | 1 | $26 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: VRAYLAR, ARISTADA, COBENFY, LYBALVI, AIRSUPRA, MOUNJARO, Leqembi, ELIQUIS.
Industry payments across MI — which companies pay providers there.
